Safety, tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator PB-201 and its effects on the glucose excursion profile in drug-naïve Chinese patients with type 2 diabetes: a randomised controlled, crossover, single-centre phase 1 trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2021

Year

Dongyang Liu, Ying Du, Xueting Yao, Yudong Wei, Jixiang Zhu, Cheng Cui, Hong Zhou, Min Xu, Haiyan Li, Linong Ji

EClinicalMedicine

Abstract

References